Tag: NASDAQ:GILD
-
Exxon Mobil Net Profit Drops 28% to $8.22 Billion, Atlassian Surprises with Revenue Boost and Co-CEO Exit, and More in Earnings
Exxon Mobil (NYSE:XOM) – Shares of Exxon Mobil are down 1.7% in pre-market trading after reporting first-quarter earnings below forecasts, affected by pressure on refining margins and falling natural gas prices. Earnings per share were $2.06, versus the expected $2.20. Revenue exceeded expectations, totaling $83.08 billion compared to the forecast of $78.35 billion. Net profit…
-
U.S. Futures Drop in Pre-Market Trading as Tech Stocks Plunge After Meta Issues Gloomy Forecast
U.S. index futures fell in pre-market trading on Thursday, particularly technology stocks, which saw a significant depreciation after Meta Platforms (NASDAQ:META) announced disheartening forecasts. At 6:44 AM, the Dow Jones (DOWI:DJI) futures were down 257 points, or 0.66%. The S&P 500 futures fell by 0.64%, and the Nasdaq-100 futures lost 0.95%. The yield on 10-year…
-
Moody’s Downgrades NYCB to Junk Status, Ford Declares Special Dividend, and Other Market Updates
Moody’s (NYSE:MCO), New York Community Bancorp (NYSE:NYCB) – Moody’s downgraded the long-term and some short-term ratings of New York Community Bancorp to junk on Tuesday, with warnings of potential downgrades. The downgrade reflects high governance risks and potential sensitivity to confidence due to significant losses in commercial real estate loans. NYCB shares are down 9.76%…
-
US Index Futures Mixed, Oil Prices Edge Higher
U.S. index futures show a mixed behavior, reflecting the volatility brought about by a recent rise in Treasury yields and the growing market anxiety that the Federal Reserve might adopt a more cautious stance on interest rate cuts than initially anticipated by Wall Street. At 06:00 AM, Dow Jones futures (DOWI:DJI) fell 65 points, or…
-
Arcus Biosciences Stock Jumps 20% on $320M Gilead Investment, Super Micro Surpasses Forecasts, and More News
Arcus Biosciences (NYSE:RCUS), Gilead Sciences (NASDAQ:GILD) – Arcus Biosciences‘ shares rose 19.5% in pre-market trading on Tuesday following news of a $320 million investment by Gilead Sciences, which also led to a revision of their collaboration agreement. This change aims to boost the growth of their joint development programs and includes the appointment of Johanna…
-
Crypto this Friday: Cryptocurrencies Reach New Highs, Kwon’s Extradition Approved, and More
Recovery and new records in the cryptocurrency market The cryptocurrency market showed a remarkable recovery on Friday. Bitcoin (COIN:BTCUSD) reached $38,253.20 at the time of publication, with a 7-day increase of 5.83%. Ether (COIN:ETHUSD) also exceeded expectations, crossing the $2,000 mark, up 3%, at $2,123.12, with a weekly gain of 8.20%. Meanwhile, Solana (COIN:SOLUSD) rose…
-
Wednesday’s Wall Street Highlights: Spirit AeroSystems, Upstart, Toast, Upwork, Take-Two, Sleep Number, and more
U.S. index futures signal a muted opening in Wednesday’s pre-market as investors assess the impact of the recently released inflation rate in Germany and review corporate earnings results. The market is on hold, awaiting remarks from Jerome Powell, the Federal Reserve Chairman, which could provide new clues on the direction of monetary policy. As of…
-
Tuesday’s Wall Street Highlights: WeWork, UBS, Sanofi, Alteryx, Intel, and more.
U.S. index futures point to a negative opening this Tuesday, signaling a cautious reaction from investors to recent mixed corporate earnings and unfavorable economic indicators coming from Europe. The market also remains in anticipation of insights from Federal Reserve members and the impending release of American trade balance data, elements that may provide additional direction…
-
Keep An Eye Out: Pre-Market Movers And Recommendations
ANALYST RECOMMENDATIONS: Biogen (NASDAQ:BIIB): RBC Capital maintains its outperform rating and reduces the target price from $357 to $351 Cbre (NYSE:CBRE): Raymond James maintains its strong buy recommendation and reduces the target price from $100 to $95. Csx (NASDAQ:CSX): Barclays maintains its overweight recommendation and reduces the target price from $40 to $38. Diamondback (NASDAQ:FANG):…
-
Keep An Eye Out: Pre-Market Movers And Recommendations
The New York pre-market is trading with much smaller losses than those in Europe (Dow Jones futures -0.22%, S&P 500 -0.24%, Nasdaq -0.28%) and is awaiting a flurry of key indicators for the day. In sequence, we will see the August trade balance at 9:30 AM, service PMIs, S&P Global at 10:45 AM and ISM,…